The IND supports the initiation of a phase 1 clinical trial, BL-M17D1-ST-101, to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of BL-M17D1 for the treatment of patients ...

In a previous study comparing the efficacy and tolerability of magnesium and sodium salts of valproic acid in 45 patients with various forms of epilepsy, Matera et al. [13] found an overall ...

TD Cowen analyst Marc Frahm has maintained their bullish stance on JANX stock, giving a Buy rating on October 31. Marc Frahm’s rating is ...

医脉通导读本项研究是迄今针对布南色林治疗精神分裂症的最全面的meta分析，共纳入15项随机对照研究，规模较2013年（4项）和2019年（10项）meta分析明显提升。分析显示，布南色林用于精神分裂症患者时通常有效且可耐受，与其他一些常用抗精神病药的 ...

The primary objective of the OASIS trial is to assess the safety and tolerability of Imugene’s onCARlytics (CF33-CD19) when ...

Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...

引言I型神经纤维瘤病(NF1)是由NF1基因突变引起的常染色体显性遗传性疾病，患病率约为1/4000-1/2000，患者多幼年起病，临床表现以咖啡牛奶斑和多发性神经纤维瘤为特征[1]。其中约50%的患者会出现丛状纤维神经瘤（PN）[2]，NF1-PN ...

This was over 28 days in a phase 1 trial. The level of weight loss and the tolerability of the treatment at 100-milligram ...

Detailed price information for Akero Therapeutics Inc (AKRO-Q) from The Globe and Mail including charting and trades.

AstraZeneca and Eccogene revealed promising trial data on ECC5004, an oral GLP-1 receptor agonist for obesity, showing safety ...

Phase 3 pivotal trial underway evaluating RMC-6236 in patients with metastatic pancreatic ductal adenocarcinoma (PDAC), supported by compelling ...